1 citations
,
September 2012 in “TURKDERM” In this study, alopecia areata patients reported higher anxiety, depression, and lower quality of life compared to those with androgenetic alopecia and healthy controls.
December 2025 in “Editora Pasteur eBooks” A combined medical and aesthetic approach is crucial for effectively managing PCOS and its skin-related issues.
April 2024 in “REVISTA INTERDISCIPLINAR CIÊNCIAS MÉDICAS” In this study, 41% of participants reported experiencing alopecia post-COVID-19, with notable associations found between the condition and female sex, azithromycin use, and symptoms like fatigue and post-infection skin irritation.
January 2023 in “Surgical & Cosmetic Dermatology” This study examined the effectiveness of using intradermotherapy, with or without microneedling and topical solutions, in reducing hair loss among men with androgenetic alopecia, though results are not reported in the abstract.
June 2026 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This study concluded that 5% topical Minoxidil remains a first-line treatment for female androgenetic alopecia by increasing hair density and thickness, while low-dose oral Minoxidil and combination therapies may also be effective.
March 2026 in “Editora Pasteur eBooks” This study conducted a narrative literature review on androgenetic alopecia, highlighting the clinical diagnosis and management strategies, including minoxidil and 5-alpha-reductase inhibitors for men, and antiandrogens for women, along with the use of aesthetic procedures like microneedling as complementary therapies.
December 2025 in “Ciencia Latina Revista Científica Multidisciplinar” In this systematic review, researchers found that nanotopical systems like nanoparticles and liposomes significantly improved hair density, thickness, and follicular regeneration markers in alopecia treatment, sometimes surpassing traditional therapies like topical minoxidil, though methodological limitations remain such as insufficient long-term clinical trials.
November 2025 in “Aurum Revista Multidisciplinar” This study found that microneedling combined with growth factors significantly improved blood circulation, hair thickness, strand resistance, and psychological well-being in patients with androgenetic alopecia, suggesting this combination as a promising and safe treatment option.
October 2025 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” In this study, researchers found significant neuropsychiatric complications from dengue infection, such as anxiety, depression, and even mania, during acute and recovery phases, linked to inflammatory responses and potential direct viral effects on the central nervous system.
October 2025 in “Cermin Dunia Kedokteran” This article discusses the diagnosis, etiology, and treatment of PTSD, highlighting the complexities and importance of effective psychotherapy and pharmacotherapy for reducing symptoms.
September 2025 in “Cermin Dunia Kedokteran” This review highlights the importance of implementing dementia screening and cognitive evaluation in primary care to better prepare healthcare providers for managing cognitive impairment in the aging population.
May 2025 in “LUMEN ET VIRTUS” This study reports that perioperative nursing care for hair transplant patients improves outcomes by reducing complications and enhancing patient satisfaction, emphasizing the crucial role of nurses in managing the procedure.
This study concluded that phytotherapy offers a potentially effective and safer alternative to conventional treatments for androgenetic alopecia by reducing hair loss progression without the usual adverse effects.
In this narrative review, researchers evaluated existing literature on the treatment of frontal fibrosing alopecia, finding that while no curative treatment exists, clinical improvements can be achieved through personalized and combined therapy approaches.
September 2024 in “Revista Científica de Salud BIOSANA” This systematic review explored the potential of cetirizine, an anti-inflammatory antihistamine, as a complementary treatment for androgenetic alopecia, reporting that it might help prevent hair follicle miniaturization by reducing inflammation and modulating immune activity, without notable side effects.
March 2024 in “Nevşehir Hacı Bektaş Veli Üniversitesi SBE Dergisi” In this study, a child with Alopecia Areata underwent art therapy, leading to reduced anxiety and stress levels and improved emotional expression and motivation for treatment, suggesting art therapy as a suitable psychosocial intervention for this condition.
January 2024 in “Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica/Revista de la Asociacion Colombiana de Dermatologia y Cirugia Dermatologica” This case report highlights the successful treatment of alopecia areata universalis with Baricitinib, suggesting potential long-term effectiveness of janus kinase inhibitors for this autoimmune hair loss condition.
November 2023 in “Cermin Dunia Kedokteran” In this case report, a girl with tinea capitis experienced psychological disorders, but oral and topical treatment with griseovulfin led to both clinical and psychological improvement, as assessed by CDQLI and DMHC methods.
This review explores the connection between COVID-19 infection and telogen effluvium, highlighting the potential contribution of inflammatory and emotional factors to hair loss; it reports no clinical results.
This article discusses the organizational aspects of the II National Academic Congress of Dermatology in Brazil and reports no new research findings.
October 2021 in “Más dermatología” Female androgenetic alopecia affects many women, is reversible with treatment like Minoxidil, and has significant psychological impacts.
January 2021 in “Revista Dermatológica Centro Uraga” This review emphasizes the importance of endocrinologic evaluation in acne patients due to its association with endocrine disorders like hyperandrogenism; it reports no new clinical results.
May 2019 in “International journal of advanced chemistry” In this study, researchers formulated a green depilatory cream from natural extracts like turmeric and aloe vera, finding it reduced hair growth by 25% in mice without causing skin irritation, suggesting it may be safer than conventional options.
September 2016 in “Más dermatología” New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.
August 2008 in “European Neuropsychopharmacology” RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.
75 citations
,
January 2014 in “Archiv Der Pharmazie” This review discusses the synthesis and biological activities of jasmonates, highlighting their potential as drugs and prodrugs, but reports no new clinical results; further research and trials are anticipated.
38 citations
,
January 2016 in “Cell Death and Disease” This review discusses the role of the TCL1 transgenic mouse model in understanding chronic lymphocytic leukemia biology and highlights the importance of exploring new pathogenetic and therapeutic targets.
19 citations
,
June 2001 in “Annals of Internal Medicine” This case report describes total alopecia in a 53-year-old woman after 13 months of tamoxifen treatment for breast cancer, with normal hair distribution maintained elsewhere.
18 citations
,
October 2020 in “PLoS ONE” This study highlights the interconnected emotional distress between patients with end-stage COPD and their family caregivers, emphasizing that both parties' functional and emotional variables influence each other's distress.
12 citations
,
October 2012 in “Anais Brasileiros De Dermatologia” This study found that dermoscopy is an effective tool for diagnosing and monitoring androgenetic alopecia in women, as it helped identify common signs such as hair miniaturization and peripilar brown halo.